Volume 179, Issue 10 (October 2022)

EDITOR’S NOTE

1. Opioid Use Disorder, Cannabis Use Disorder, and a Mindfulness Intervention Affecting Pain-Related Neural Substrates

EDITORIALS

2. Understanding the Risks of Long-Term Opioid Therapy for Chronic Pain

3. Flexible Buprenorphine/Naloxone Treatment Models: Safe and Effective in Reducing Opioid Use Among Persons With Prescription Opioid Use Disorder

4. Understanding Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration in the Era of Legalization

5. Can You Feel the Burn? Using Neuroimaging to Illuminate the Mechanisms of Mindfulness Interventions for Pain

REVIEWS AND OVERVIEWS

6. Opioid Use Disorder: Pernicious and Persistent

ARTICLES

7. Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain

8. Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial

9. Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder

10. Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005–2019

11. Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial

APA OFFICIAL ACTIONS

12. Reports to the Membership

CORRECTION

13. Correction to Wielgosz et al.